Delivery Order SPE2DB22D1017-SPE2DB25FF0NX

Award Date 12/4/24
Potential Completion Date 12/5/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF0NX
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,127.00, is for the delivery of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots. The contract has a firm fixed price and an ultimate completion date of December 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition. The contract aligns with the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces, other federal agencies, and international partners.

Generated 3/5/25, 10:08 AM